NCT PPP module – the future
Dr. Roy was optimistic that the government was taking steps to ensure that certain services are made available to the public under the Public Private Partnership (PPP) model. For eg; availability of mammography, biopsies at the diagnostic level is being envisaged as the rollout for the program; As a part of the aspirational plan, Cardiology- coronary angiography would be available at the District hospitals under Ayushman Bharat PMJAY scheme, and for Pulmonology- clinical examination during screening and PCG, bronchoscopy x-ray for diagnostics.
He lauded the ministry of health for having partnered with NICE (National Institute of Clinical Excellence), known for making the best guidelines in the world. Over the last three and a half years, jointly, they have come up with standard treatment guidelines for the district hospital. These guidelines will surely make all the health workers well aware of standard treatments and will help in overcoming ad-hoc treatments based on personal belief systems. The patient flow pathway algorithms are a part of it including patient education material. These may serve to build our algorithms for AI, if implemented well.
Adding to this. Dr. Roy mentioned that pathology pap smear was very amenable to AI. And this was a clear example of how AI can be looked at. The productivity of the pathologists can be enhanced using AI in this sphere. With a limited number of pathologists available to be able to look at all these slides that are likely to be generated by screening, could both time-consuming as well as tedious. So, it would make sense to get at least the initial screening aided by AI.
Like-wise in the case of sputum microscopic, Dr. Roy hoped that where there are already various models in play, there needed to be capabilities of tying up teleradiology with tele-pathology. Dr. Roy believed that this was the space where it would pose a real challenge because according to him most image-based scans, even the retinal scans were proficient for mass screenings. Ethical issues with regards to data sharing will remain and will accompany the regulatory aspect of it. Real ethical and legal challenges notwithstanding, AI can potentially score in electronic health records, big data, epidemiology outbreak, and crowdsourcing. The aim should be augmented intelligence and it is multidisciplinary as the industry needs to get the doctors, data engineers, legal and social scientists, and the logisticians together. There is also the need for a strong curriculum to handle big data as the industry lacks in the same and thus it can’t be used effectively, Dr. Roy concluded.